Acadia Pharma (ACAD) Files 20M Common Shelf
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Join SI Premium – FREE
Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 20 million shares of its Common Stock.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- Breeze Acquisition Corp. II gets Nasdaq notice for late 10-Q filings
- Gossamer Bio raises up to $250M in private placement for PAH drug
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
